Prime Therapeutics

primetherapeutics.com · Eagan, United States of America

Prime Therapeutics is a pharmacy benefit manager that partners with health plans, employers, and government programs to manage prescription drug benefits, control pharmacy costs, and improve medication outcomes for members. The company negotiates with drug manufacturers and pharmacies, administers formularies and clinical programs, and processes pharmacy claims on behalf of its clients. It generates revenue primarily through administrative fees, spread pricing, and shared savings arrangements tied to drug spend management.

  • IT Consulting & Implementation
  • Business Intelligence & Dashboards
Revenue
$8.0B
Employees
4,500
Founded
1998
Headquarters
Eagan, United States of America

What 9 Arbolus experts think of Prime Therapeutics

NPS data ranges from 2 (low) to 10 (high), with a cluster of scores in the 7–9 range, suggesting generally positive customer sentiment and satisfaction. Among those reporting renewal intent, the majority are not sure, although overall stickiness is high, as 100% report being in the 'More Than 1 Year' implementation stage. Most users report consistent and positive experiences after extended usage, though there is some ambivalence about future renewal, primarily from high spenders.Overall Customer Sentiment: Positive

Who reviewed Prime Therapeutics

Total customers 9 8 current · 1 former
Reviews growth +9 in six months
Seniority of respondents
  • C-Suite 67% (6)
  • Director 11% (1)
  • Manager 22% (2)
Operations Ops Manager NPS 8
Product Leader C-Suite NPS 7
Other Generalist C-Suite NPS 2 Will renew

Employer names and spend open once the report publishes.

Tell us when the Prime Therapeutics report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Notify me

Sentiment

0 Net Promoter Score, from 9 scored reviews
  • Promoters 2
  • Passives 5
  • Detractors 2

Cumulative NPS by month

-1 over 4 months
  • Jan 8
  • Apr 7
  • May 7
  • Jun 7

Net Promoter Score across 1 reviews, accumulated up to each month. Category median 0 across 1 companies.

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 33%
  • Will renew 1
  • Undecided 2
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 50% 2 answers
  • Manager 0% 1 answer
  • 2/10 Average score from customers who will renew
  • 8/10 Average score from undecided customers

For people who use Prime Therapeutics

Do you use Prime Therapeutics at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 9 customers of Prime Therapeutics have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.